Drug Research
Targovax ASA and Agenus announce collaboration on mutant KRAS cancer vaccine adjuvanted with QS-21 STIMULON
Targovax ASA, a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, and Agenus, an immuno-oncology company with an extensive pipeline of...
Articles
Challenges of variations in tub packaging
“Why double-bagged tubs are an issue for high-speed filling lines”?
Fully automated production is fast becoming the standard for the biopharmaceutical manufacturing industry. At the...
News
For Stakeholders Bidens Bid To Cut Drug Costs Is A Top Issue
Much of the reaction to President Joe Biden's State of the Union address concentrated on the president's repeated calls for Congress to allow Medicare...
News
The UK Government Announces £260 Million To Fix Healthcare
The UK government has put forth its intention to invest £260 million in cutting-edge medical research and development, as well as the manufacturing of innovative...
News
Untreatable Lung Cancer Patients Get Breakthrough Treatment
The head of the NHS revealed today that a breakthrough targeted medication treating lung cancer would be made accessible to anybody who qualifies, owing...
News
Exclusive license for Croda to commercialise SSI’s CAF vaccine adjuvants
Croda International Plc, which uses smart science to improve lives, announces that it has entered a strategic collaboration with Statens Serum Institut (“SSI”), the...
Press Releases
Vetter’s extraordinary performance sweeps the board at the 2022 CMO Leadership Awards
Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), won the 2022 CMO Leadership Awards in all six core categories – quality, expertise,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read